Collard Craig A
Insider CIK 1363558 · CRTX Chief Executive Officer, Director, 10% owner · SRRA Director · OPNT Director · TRSSF Director · HRTX Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-10-19 | 2026-10-21 | 13,797 | — | $0 | 68,984 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2026-10-19 | 2026-10-21 | 3,360 | $0.36 | $1.2K | 866,929 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-10-19 | 2026-10-21 | 13,797 | — | — | 870,289 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-07-31 | 2026-08-03 | 34,789 | — | $0 | 347,886 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-07-31 | 2026-08-03 | 34,789 | — | $0 | 856,492 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-07-31 | 2026-08-03 | 34,789 | — | $0 | 347,886 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-07-31 | 2026-08-03 | 34,789 | — | — | 856,492 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-07-30 | 2026-08-03 | 50,021 | — | $0 | 700,295 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-07-30 | 2026-08-03 | 50,021 | — | $0 | 821,703 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-07-30 | 2026-08-03 | 50,021 | — | $0 | 700,295 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-07-30 | 2026-08-03 | 50,021 | — | — | 821,703 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-07-19 | 2026-07-20 | 13,797 | — | $0 | 82,781 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-07-19 | 2026-07-20 | 13,797 | — | $0 | 771,682 | SEC↗ |
| TSNDF TerrAscend Corp. | D To issuer deriv | 2026-06-24 | 2026-06-25 | 150,000 | — | $0 | 0 | SEC↗ |
| TSNDF TerrAscend Corp. | A Award deriv | 2026-06-24 | 2026-06-25 | 150,000 | — | $0 | 150,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-04-30 | 2026-05-04 | 50,021 | — | $0 | 750,316 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-04-30 | 2026-05-04 | 34,789 | — | $0 | 382,675 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-04-30 | 2026-05-04 | 50,021 | — | $0 | 757,885 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-04-30 | 2026-05-04 | 34,789 | — | $0 | 696,841 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-04-19 | 2026-04-21 | 13,797 | — | $0 | 96,758 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-04-19 | 2026-04-21 | 13,797 | — | $0 | 662,052 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-04-03 | 2026-04-06 | 62,500 | — | $0 | 62,500 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-04-03 | 2026-04-06 | 62,500 | — | $0 | 648,255 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-01-31 | 2026-02-03 | 34,789 | — | $0 | 417,464 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-01-31 | 2026-02-03 | 34,789 | — | $0 | 571,710 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2026-01-30 | 2026-02-03 | 800,336 | — | $0 | 800,336 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2026-01-30 | 2026-02-03 | 800,337 | — | $0 | 800,337 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-01-19 | 2026-01-20 | 13,797 | — | $0 | 110,375 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-01-19 | 2026-01-20 | 13,797 | — | $0 | 536,921 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2025-10-31 | 2025-11-04 | 34,789 | — | $0 | 452,253 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2025-10-31 | 2025-11-04 | 34,789 | — | $0 | 523,124 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2025-10-19 | 2025-10-21 | 13,797 | — | $0 | 124,172 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2025-10-19 | 2025-10-21 | 13,797 | — | $0 | 488,335 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2025-07-31 | 2025-08-04 | 34,789 | — | $0 | 487,042 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2025-07-31 | 2025-08-04 | 34,789 | — | $0 | 474,538 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2025-07-19 | 2025-07-22 | 13,797 | — | $0 | 137,969 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2025-07-19 | 2025-07-22 | 13,797 | — | $0 | 439,749 | SEC↗ |
| TSNDF TerrAscend Corp. | A Award | 2025-06-24 | 2025-06-25 | 433,653 | — | $0 | 1,076,538 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2025-04-30 | 2025-05-02 | 34,789 | — | $0 | 521,831 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2025-04-30 | 2025-05-02 | 34,789 | — | $0 | 425,952 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2025-04-19 | 2025-04-22 | 13,796 | — | $0 | 151,766 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2025-04-19 | 2025-04-22 | 13,796 | — | $0 | 391,163 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2025-04-03 | 2025-04-03 | 62,500 | — | $0 | 125,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2025-04-03 | 2025-04-03 | 62,500 | — | $0 | 377,367 | SEC↗ |
| TSNDF TerrAscend Corp. | F Tax w/h | 2025-03-25 | 2025-03-26 | 2,258 | $0.46 | $1.0K | 642,885 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2025-01-31 | 2025-02-04 | 556,620 | — | $0 | 556,620 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2025-01-31 | 2025-02-04 | 1,113,240 | — | $0 | 1,113,240 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2025-01-19 | 2025-01-22 | 13,797 | — | $0 | 165,562 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2025-01-19 | 2025-01-22 | 13,797 | — | $0 | 314,867 | SEC↗ |
| TSNDF TerrAscend Corp. | F Tax w/h | 2024-12-31 | 2025-01-03 | 71,704 | $0.65 | $46.6K | 645,143 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2024-10-19 | 2024-10-21 | 13,797 | — | $0 | 179,359 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2024-10-19 | 2024-10-21 | 13,797 | — | $0 | 290,387 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2024-07-19 | 2024-07-22 | 13,797 | — | $0 | 193,156 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2024-07-19 | 2024-07-22 | 13,797 | — | $0 | 276,590 | SEC↗ |
| TSNDF TerrAscend Corp. | A Award deriv | 2024-06-17 | 2024-06-20 | 150,000 | — | $0 | 150,000 | SEC↗ |
| TSNDF TerrAscend Corp. | D To issuer deriv | 2024-06-17 | 2024-06-20 | 150,000 | — | $0 | 0 | SEC↗ |
| TSNDF TerrAscend Corp. | A Award | 2024-06-17 | 2024-06-20 | 163,334 | — | $0 | 716,847 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2024-04-19 | 2024-04-19 | 13,797 | — | $0 | 262,793 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2024-04-03 | 2024-04-05 | 62,500 | — | $0 | 187,500 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2024-04-03 | 2024-04-05 | 62,500 | — | $0 | 248,996 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2024-01-19 | 2024-04-19 | 13,797 | — | $0 | 206,953 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2024-01-19 | 2024-01-19 | 220,750 | — | $0 | 220,750 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2024-01-19 | 2024-01-19 | 1,324,502 | — | $0 | 1,324,502 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | P Buy | 2023-11-16 | 2023-11-17 | 150,000 | $0.92 | $138.0K | 186,496 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2023-08-22 | 2023-08-24 | 692 | $1.65 | $1.1K | 36,496 | SEC↗ |
| TRSSF TerrAscend Corp. | A Award | 2023-06-22 | 2023-06-26 | 132,647 | — | $0 | 553,513 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2023-05-22 | 2023-05-24 | 691 | $1.45 | $1.0K | 37,188 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2023-04-03 | 2023-04-05 | 3,000,000 | — | $0 | 3,000,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2023-04-03 | 2023-04-05 | 4,250,000 | — | $0 | 4,250,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2023-04-03 | 2023-04-05 | 250,000 | — | $0 | 250,000 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer deriv | 2023-03-02 | 2023-03-03 | 5,000 | — | $0 | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer deriv | 2023-03-02 | 2023-03-03 | 2,500 | — | $0 | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer deriv | 2023-03-02 | 2023-03-03 | 2,500 | — | $0 | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer deriv | 2023-03-02 | 2023-03-03 | 2,500 | — | $0 | 0 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer | 2023-03-02 | 2023-03-03 | 53,822 | $20.00 | $1.08M | 2,000 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | D To issuer | 2023-03-02 | 2023-03-03 | 2,000 | $20.00 | $40.0K | 0 | SEC↗ |
| TRSSF TerrAscend Corp. | P Buy | 2022-09-23 | 2022-09-27 | 60,000 | — | $0 | 420,866 | SEC↗ |
| TRSSF TerrAscend Corp. | P Buy | 2022-09-22 | 2022-09-26 | 120,000 | — | $0 | 360,866 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 10,000 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 6,000 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer | 2022-07-01 | 2022-07-01 | 13,500 | $55.00 | $742.5K | 0 | SEC↗ |
| TRSSF TerrAscend Corp. | A Award | 2022-06-27 | 2022-06-29 | 36,496 | — | $0 | 162,948 | SEC↗ |
| TRSSF TerrAscend Corp. | A Award | 2022-06-27 | 2022-06-29 | 77,918 | — | $0 | 240,866 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award | 2022-06-14 | 2022-06-14 | 2,000 | — | $0 | 55,822 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | P Buy | 2022-06-13 | 2022-06-13 | 4,037 | $10.94 | $44.2K | 53,822 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | P Buy | 2022-06-10 | 2022-06-13 | 1,663 | $11.50 | $19.1K | 49,785 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | P Buy | 2022-05-16 | 2022-05-17 | 27,150 | $13.54 | $367.6K | 48,122 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | P Buy | 2022-05-13 | 2022-05-16 | 3,689 | $10.49 | $38.7K | 20,972 | SEC↗ |
| TRSSF TerrAscend Corp. | X Exercise deriv | 2022-01-06 | 2022-01-10 | 52,939 | — | $0 | 0 | SEC↗ |
| TRSSF TerrAscend Corp. | X Exercise | 2022-01-06 | 2022-01-10 | 52,939 | $2.54 | $134.5K | 126,452 | SEC↗ |
| SRRA Sierra Oncology, Inc. | P Buy | 2021-11-24 | 2021-11-24 | 7,899 | $23.09 | $182.4K | 13,500 | SEC↗ |
| SRRA Sierra Oncology, Inc. | P Buy | 2021-11-23 | 2021-11-24 | 5,601 | $22.95 | $128.5K | 5,601 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award | 2021-09-13 | 2021-09-15 | 700 | $18.07 | $12.6K | 17,283 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | P Buy | 2021-09-13 | 2021-09-15 | 2,500 | $18.13 | $45.3K | 16,077 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award | 2021-09-13 | 2021-09-15 | 506 | $17.96 | $9.1K | 16,583 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | P Buy | 2021-09-10 | 2021-09-13 | 9,577 | $18.18 | $174.1K | 13,577 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award deriv | 2021-06-15 | 2021-06-16 | 2,500 | — | $0 | 2,500 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award | 2021-06-15 | 2021-06-16 | 2,000 | — | $0 | 4,000 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2021-06-08 | 2021-06-09 | 6,000 | — | $0 | 6,000 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award deriv | 2020-06-15 | 2020-06-15 | 2,500 | — | $0 | 2,500 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award | 2020-06-15 | 2020-06-15 | 2,000 | — | $0 | 2,000 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2020-05-28 | 2020-05-29 | 10,000 | — | $0 | 10,000 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award deriv | 2019-06-12 | 2019-06-13 | 2,500 | — | $0 | 2,500 | SEC↗ |
| OPNT OPIANT PHARMACEUTICALS, IN | A Award deriv | 2018-10-29 | 2018-10-31 | 5,000 | — | $0 | 5,000 | SEC↗ |
| CRTX CORNERSTONE THERAPEUTICS I | D To issuer deriv | 2014-02-03 | 2014-02-04 | 200,000 | $4.24 | $848.0K | 0 | SEC↗ |
| CRTX CORNERSTONE THERAPEUTICS I | D To issuer deriv | 2014-02-03 | 2014-02-04 | 11,904 | $9.07 | $108.0K | 0 | SEC↗ |
| CRTX CORNERSTONE THERAPEUTICS I | D To issuer deriv | 2014-02-03 | 2014-02-04 | 238,083 | $7.73 | $1.84M | 0 | SEC↗ |
| CRTX CORNERSTONE THERAPEUTICS I | D To issuer deriv | 2014-02-03 | 2014-02-04 | 35,712 | $5.60 | $200.0K | 0 | SEC↗ |
| CRTX CORNERSTONE THERAPEUTICS I | D To issuer deriv | 2014-02-03 | 2014-02-04 | 50,000 | $2.41 | $120.5K | 0 | SEC↗ |
| CRTX CORNERSTONE THERAPEUTICS I | D To issuer deriv | 2014-02-03 | 2014-02-04 | 95,000 | $4.25 | $403.8K | 0 | SEC↗ |
| CRTX CORNERSTONE THERAPEUTICS I | D To issuer deriv | 2014-02-03 | 2014-02-04 | 95,000 | $3.76 | $357.2K | 0 | SEC↗ |
| CRTX CORNERSTONE THERAPEUTICS I | D To issuer | 2014-02-03 | 2014-02-04 | 1,567,225 | $9.50 | $14.89M | 0 | SEC↗ |
| CRTX CORNERSTONE THERAPEUTICS I | D To issuer | 2014-02-03 | 2014-02-04 | 45,000 | $9.50 | $427.5K | 0 | SEC↗ |
| CRTX CORNERSTONE THERAPEUTICS I | A Award | 2013-03-05 | 2013-03-07 | 45,000 | — | $0 | 1,612,225 | SEC↗ |
| CRTX CORNERSTONE THERAPEUTICS I | S Sale | 2012-04-03 | 2012-04-03 | 1,443,913 | $6.25 | $9.02M | 0 | SEC↗ |
| CRTX CORNERSTONE THERAPEUTICS I | A Award deriv | 2012-02-29 | 2012-04-03 | 95,000 | — | $0 | 95,000 | SEC↗ |